Catalog No.
RQB91701
Species reactivity
Dog
Host species
Mouse
Isotype
IgG2a, kappa
Clonality
Monoclonal
Target
Beta-nerve growth factor, NGFB, Beta-NGF, NGF
Concentration
0.79 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
Q531B0
Applications
Blocking, ELISA, IF, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
SAA0479
Maternal F1 antibodies and cytokines in mother-neonate dog pairs in the Marmota himalayana plague focus., PMID:39991224
Re: Re: Laboratory safety evaluation of bedinvetmab, a canine anti-nerve growth factor monoclonal antibody, in dogs., PMID:38885831
The expression of nerve growth factor in healthy and inflamed equine chondrocytes analysed by capillary western immunoassay., PMID:36029605
Laboratory safety evaluation of bedinvetmab, a canine anti-nerve growth factor monoclonal antibody, in dogs., PMID:34391918
Expression and Prognostic Significance of Neurotrophins and Their Receptors in Canine Mammary Tumors., PMID:32351171
Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats., PMID:30368458
A Feline-Specific Anti-Nerve Growth Factor Antibody Improves Mobility in Cats with Degenerative Joint Disease-Associated Pain: A Pilot Proof of Concept Study., PMID:27334504
In Vitro and In Vivo Characterization of a Fully Felinized Therapeutic Anti-Nerve Growth Factor Monoclonal Antibody for the Treatment of Pain in Cats., PMID:27306920
A canine-specific anti-nerve growth factor antibody alleviates pain and improves mobility and function in dogs with degenerative joint disease-associated pain., PMID:25926287
Canine Brief Pain Inventory scores for dogs with osteoarthritis before and after administration of a monoclonal antibody against nerve growth factor., PMID:24866508
A fully caninised anti-NGF monoclonal antibody for pain relief in dogs., PMID:24206926
Sequential protein and peptide immunoaffinity capture for mass spectrometry-based quantification of total human β-nerve growth factor., PMID:23249404
Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain., PMID:21907491
Effects of high thoracic epidural anesthesia on atrial electrophysiological characteristics and sympathetic nerve sprouting in a canine model of atrial fibrillation., PMID:21318296
Pathological sprouting of adult nociceptors in chronic prostate cancer-induced bone pain., PMID:21048122
In vitro and in vivo gene therapy with CMV vector-mediated presumed dog beta-nerve growth factor in pyridoxine-induced neuropathy dogs., PMID:19043311
Investigating TrkA expression in canine appendicular osteosarcoma., PMID:18638015
Co-expression of nerve growth factor and p75NGFR in the inferior alveolar nerve after mandibular distraction osteogenesis., PMID:18346878
A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone., PMID:16230406
Nerve growth factor and corneal wound healing in dogs., PMID:15862170
Immunological and chemical characterization of glycoproteins in IEF fractions of Blastomyces dermatitidis yeast lysate antigen., PMID:9375492
Protective role of nerve growth factor against postischemic dysfunction of sympathetic coronary innervation., PMID:8994439
An internal deletion in the cytoplasmic tail reverses the apical localization of human NGF receptor in transfected MDCK cells., PMID:1655809
For research use only. Not for human or drug use.
